Literature DB >> 11336065

Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.

R McMillan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11336065     DOI： 10.1056/NEJM200105033441815

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.

Authors:  Lisa J Toltl; Donald M Arnold
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

2.  Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.

Authors:  James B Bussel; Christina S Lee; Caroline Seery; Allison A Imahiyerobo; Michaela V Thompson; Diane Catellier; Ithamar G Turenne; Vivek L Patel; Paul A Basciano; Rebecca L Elstrom; Waleed Ghanima
Journal:  Haematologica       Date:  2014-04-18       Impact factor: 9.941

3.  Repeated courses of rituximab in chronic ITP: Three different regimens.

Authors:  Aisha Hasan; Marc Michel; Vivek Patel; Roberto Stasi; Susanna Cunningham-Rundles; John P Leonard; James Bussel
Journal:  Am J Hematol       Date:  2009-10       Impact factor: 10.047

Review 4.  Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.

Authors:  Oriana Miltiadous; Ming Hou; James B Bussel
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

5.  Long-term management of chronic immune thrombocytopenic purpura in adults.

Authors:  Javier Palau; Isidro Jarque; Miguel A Sanz
Journal:  Int J Gen Med       Date:  2010-10-05

6.  Successful treatment with thrombopoietin receptor agonist in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia.

Authors:  Alhossain Khalafallah; Zafreen Rahman; Kath Ogden; Terry Hannan
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-01-18       Impact factor: 2.576

7.  Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.

Authors:  Susan D Mathias; Sue K Gao; Kimberly L Miller; David Cella; Claire Snyder; Ralph Turner; Albert Wu; James B Bussel; James N George; Robert McMillan; Diane Kholos Wysocki; Janet L Nichol
Journal:  Health Qual Life Outcomes       Date:  2008-02-08       Impact factor: 3.186

Review 8.  Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.

Authors:  Nicola Vianelli; Giuseppe Auteri; Francesco Buccisano; Valentina Carrai; Erminia Baldacci; Cristina Clissa; Daniela Bartoletti; Gaetano Giuffrida; Domenico Magro; Elena Rivolti; Daniela Esposito; Gian Marco Podda; Francesca Palandri
Journal:  Ann Hematol       Date:  2022-02-24       Impact factor: 4.030

9.  Systemic Therapy In Acquired Haemophilia - A Single Institute Experience.

Authors:  Lawless Sarah; Das Prantik; Benson Gary
Journal:  Ulster Med J       Date:  2016-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.